CLINICAL_TRIALS
trial_result
· 2022-05-16
Clinical Trial Update: Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout [Phase 4]
Summary
Phase 4 trial evaluating KRYSTEXXA (pegloticase) plus methotrexate in uncontrolled gout has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Gout | Phase 4 | Status: COMPLETED | Results posted: 2022-05-16